JP4964253B2 - Transparent sunscreen gel and method of use - Google Patents
Transparent sunscreen gel and method of use Download PDFInfo
- Publication number
- JP4964253B2 JP4964253B2 JP2008557463A JP2008557463A JP4964253B2 JP 4964253 B2 JP4964253 B2 JP 4964253B2 JP 2008557463 A JP2008557463 A JP 2008557463A JP 2008557463 A JP2008557463 A JP 2008557463A JP 4964253 B2 JP4964253 B2 JP 4964253B2
- Authority
- JP
- Japan
- Prior art keywords
- dimethicone
- composition
- crosspolymer
- mixture
- phenylvinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 14
- 239000000516 sunscreening agent Substances 0.000 title description 33
- 230000000475 sunscreen effect Effects 0.000 title description 31
- 239000000203 mixture Substances 0.000 claims description 125
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 45
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 45
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 45
- 229940008099 dimethicone Drugs 0.000 claims description 44
- 229920006037 cross link polymer Polymers 0.000 claims description 23
- -1 diphenylsiloxy Chemical group 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000002537 cosmetic Substances 0.000 claims description 19
- 239000003349 gelling agent Substances 0.000 claims description 19
- 239000000126 substance Substances 0.000 claims description 19
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 claims description 15
- 229920002379 silicone rubber Polymers 0.000 claims description 15
- 239000006096 absorbing agent Substances 0.000 claims description 14
- 235000019441 ethanol Nutrition 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 11
- 229920001296 polysiloxane Polymers 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 239000002131 composite material Substances 0.000 claims description 7
- 239000002562 thickening agent Substances 0.000 claims description 7
- RGMZNZABJYWAEC-UHFFFAOYSA-N Methyltris(trimethylsiloxy)silane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C RGMZNZABJYWAEC-UHFFFAOYSA-N 0.000 claims description 6
- 229940073663 methyl trimethicone Drugs 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 229940057874 phenyl trimethicone Drugs 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 5
- 239000006100 radiation absorber Substances 0.000 claims description 5
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims description 5
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 claims description 4
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 claims description 3
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 3
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 3
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 claims description 3
- 229960005193 avobenzone Drugs 0.000 claims description 3
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 3
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 3
- 230000009931 harmful effect Effects 0.000 claims description 3
- 229960004881 homosalate Drugs 0.000 claims description 3
- 229960001679 octinoxate Drugs 0.000 claims description 3
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 3
- 229960000601 octocrylene Drugs 0.000 claims description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical group OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 3
- 229960001173 oxybenzone Drugs 0.000 claims description 3
- 229920002050 silicone resin Polymers 0.000 claims description 3
- 239000004945 silicone rubber Substances 0.000 claims description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- 125000006267 biphenyl group Chemical group 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- 235000010290 biphenyl Nutrition 0.000 description 10
- 239000004305 biphenyl Substances 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 10
- 239000000463 material Substances 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 4
- 239000012867 bioactive agent Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- HDIFHQMREAYYJW-FMIVXFBMSA-N 2,3-dihydroxypropyl (e)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C\CCCCCCCC(=O)OCC(O)CO HDIFHQMREAYYJW-FMIVXFBMSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- OJIBJRXMHVZPLV-UHFFFAOYSA-N 2-methylpropyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(C)C OJIBJRXMHVZPLV-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- AMEMLELAMQEAIA-UHFFFAOYSA-N 6-(tert-butyl)thieno[3,2-d]pyrimidin-4(3H)-one Chemical compound N1C=NC(=O)C2=C1C=C(C(C)(C)C)S2 AMEMLELAMQEAIA-UHFFFAOYSA-N 0.000 description 1
- 239000004358 Butane-1, 3-diol Substances 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 239000004146 Propane-1,2-diol Substances 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229940030999 antipsoriatics Drugs 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000003901 ceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940033357 isopropyl laurate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- OXGBCSQEKCRCHN-UHFFFAOYSA-N octadecan-2-ol Chemical compound CCCCCCCCCCCCCCCCC(C)O OXGBCSQEKCRCHN-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/895—Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
Description
本発明は、スキンケア化粧品組成物及びその使用方法に関する。特に、本発明は、新規な透明でアルコール非含有のサンスクリーンジェル及びその使用方法に関する。 The present invention relates to skin care cosmetic compositions and methods of use thereof. In particular, the present invention relates to a novel clear, alcohol-free sunscreen gel and method of use.
日光に曝される負の影響は良く知られている。例えば、皮膚が約290〜約400nmの波長を有するUV線に曝されると、日光に長時間曝された場合には皮膚は短期間のダメージ(例えば、日焼け及び早すぎる老化)を受ける恐れがある。更に、長期間ダメージを受けると、皮膚癌のような深刻な状態が生ずる恐れがある。太陽に過度に曝されたために生ずる健康ハザードの結果として、サンスクリーン製品の需要は続いている。従って、日焼け止め含有の毎日塗る製品を含む、各種サンスクリーン製品が市販されている。サンスクリーン製品の使用が増えるにつれて、消費者の需要は太陽光線を効果的に遮るだけでなく皮膚に対して適用したとき美的に美しいサンスクリーン製品の開発を求めている。 The negative effects of exposure to sunlight are well known. For example, if the skin is exposed to UV radiation having a wavelength of about 290 to about 400 nm, the skin may be subject to short-term damage (eg, sunburn and premature aging) when exposed to sunlight for extended periods of time. is there. Furthermore, if damaged for a long time, a serious condition such as skin cancer may occur. The demand for sunscreen products continues as a result of health hazards that result from excessive exposure to the sun. Accordingly, various sunscreen products are commercially available, including sunscreen containing daily products. As the use of sunscreen products increases, consumer demand not only effectively blocks sunlight, but also requires the development of sunscreen products that are aesthetically pleasing when applied to the skin.
透明な化粧品組成物は制汗剤やヘアジェル剤に一般的に使用されている。前記組成物は典型的には、透明なエマルションを与えるように一致した屈折率を有しているポリオール及びシリコーン乳化剤を含み、別名ゲルとして知られている。しかしながら、従来の透明なサンスクリーン剤では、通常使用されているシリコーンエラストマーは日焼け止め成分を十分に増粘させないため、追加のワックスが必要とされている。残念ながら、追加のワックスは従来の透明なサンスクリーン組成物の透明性を損ね、しばしば余りに増粘された組成物を生じるため、消費者にとって魅力的でない。更に、従来のサンスクリーン組成物は典型的にはアルコールを含有しており、このアルコールのためにサンスクリーン製品を適用したとき皮膚が刺激されたり、乾燥したりすることがあり得る。 Transparent cosmetic compositions are commonly used in antiperspirants and hair gels. The composition typically includes a polyol and a silicone emulsifier having a consistent refractive index to give a clear emulsion, also known as a gel. However, conventional transparent sunscreen agents require additional wax because the commonly used silicone elastomers do not sufficiently thicken the sunscreen component. Unfortunately, additional waxes are unattractive to consumers because they detract from the transparency of conventional clear sunscreen compositions and often result in compositions that are too thick. In addition, conventional sunscreen compositions typically contain alcohol, which can irritate or dry the skin when sunscreen products are applied for this alcohol.
従って、十分な粘度を有していると同時に所望の透明性を維持し、消費者にとって美的に美しい改善された透明なサンスクリーンジェル組成物が依然として要望されている。更に、本質的にアルコールを含まないために、皮膚を刺激しない改善された透明なサンスクリーンジェル組成物が要望されている。 Accordingly, there remains a need for an improved clear sunscreen gel composition that has sufficient viscosity while maintaining the desired transparency and is aesthetically pleasing to the consumer. Furthermore, there is a need for an improved transparent sunscreen gel composition that is essentially alcohol free and therefore does not irritate the skin.
1つの態様で、本発明は、少なくとも1つの化学的紫外(UV)線吸収剤、少なくとも1つの溶媒及び少なくとも1つのジフェニルシリコーンエラストマーゲル化剤を含み、透明であり、本質的にアルコールを含まない化粧品組成物に関する。 In one aspect, the present invention includes at least one chemical ultraviolet (UV) radiation absorber, at least one solvent and at least one diphenyl silicone elastomer gelling agent, is transparent and essentially free of alcohol. The present invention relates to a cosmetic composition.
本明細書中で使用されている用語「透明」は、組成物または材料がその周囲の屈折率(RI)と一致するRIを有していること、すなわち組成物または材料がその機能的環境の範囲内で、及びその環境に対して透明であることを指す。本発明で記載されている透明な組成物または材料は、好ましくは約70%以上、より好ましくは約75%以上の光透過率を示し、光の散乱性を示さない。 As used herein, the term “transparent” means that the composition or material has an RI that matches its surrounding refractive index (RI), ie, that the composition or material is in its functional environment. To be transparent within the scope and to the environment. The transparent composition or material described in the present invention preferably exhibits a light transmission of about 70% or more, more preferably about 75% or more, and does not exhibit light scattering.
本明細書中で使用されている用語「本質的にアルコールを含まない」は、組成物または材料が組成物または材料の全重量の約0.5%未満のエチルアルコール含量しか有していないことを指す。 The term “essentially free of alcohol” as used herein means that the composition or material has an ethyl alcohol content of less than about 0.5% of the total weight of the composition or material. Point to.
別の態様で、本発明は、上記した透明な化粧品組成物を皮膚に対して適用することによって皮膚をUV線の有害な作用から保護するための該化粧品組成物の使用方法に関する。 In another aspect, the present invention relates to a method of using the cosmetic composition for protecting the skin from the harmful effects of UV radiation by applying the transparent cosmetic composition described above to the skin.
本発明の別の態様及び目的は以下の説明、実施例及び請求の範囲からより明らかとなるであろう。 Other aspects and objects of the invention will become more apparent from the following description, examples, and claims.
実施例及び比較例中、或いは他の方法で明確に示されている場合を除いて、本明細書中の材料もしくは反応条件の量もしくは比、材料の物理的特性、及び/または使用を示す数字はすべて単語「約」により修飾されると理解されたい。別段の記載がない限り、量はすべて最終組成物の重量基準である。 Numbers indicating the amount or ratio of materials or reaction conditions, physical properties of materials, and / or uses herein, except in examples and comparative examples, or where otherwise clearly indicated. Should be understood to be modified by the word “about”. Unless otherwise stated, all amounts are by weight of the final composition.
本発明において、驚くことに、特定のジフェニルシリコーンエラストマーゲル化剤及び1つ以上の特定の非アルコール溶媒を化学的UV線吸収剤と組み合わせることにより安定なアルコール非含有で透明な化粧品組成物が形成され得、この組成物が美的に魅力的な透明なサンスクリーンジェルとして特に有用であることが知見された。本明細書中で使用されている用語「安定」は、組成物が十分な物理的及び化学的安定性を有しており、すべての成分を添加したときに組成物が分離も沈降もしないことを指す。本明細書中で使用されている用語「美的に魅力的」は、組成物が皮膚に適用されたときに粉末状、ビロード様及びシルク様の質感を有していることを指す。 In the present invention, surprisingly, a stable alcohol-free and transparent cosmetic composition is formed by combining a specific diphenyl silicone elastomer gelling agent and one or more specific non-alcohol solvents with a chemical UV absorber. It has been found that this composition is particularly useful as an aesthetically attractive transparent sunscreen gel. As used herein, the term “stable” means that the composition has sufficient physical and chemical stability so that the composition does not separate or settle when all ingredients are added. Point to. As used herein, the term “aesthetically attractive” refers to having a powdery, velvety and silky texture when the composition is applied to the skin.
本発明の透明な化粧品組成物の第1の必須成分として、化学的UV線吸収剤が使用される。化学的UV線吸収剤は、化粧品組成物中に一般的に使用されている適当な化学的UV線吸収剤であり得る。適当な化学的UV線吸収剤の具体例にはベンゾフェノン−3、ホモサレート、エチルヘキシルメトキシシンナメート、アボベンゾン、エチルヘキシルサリチレート及びオクトクリレン、並びにその組合せが含まれるが、これらに限定されない。化学的UV線吸収剤は、本発明の透明な化粧品組成物中に好ましくは組成物の全重量の約1〜約20%、より好ましく約2〜約15%の範囲の量で存在している。特に、本発明の透明な化粧品組成物は、組成物の透明性を損なうと知られている物理的UV吸収剤(例えば、酸化チタン及び酸化亜鉛)を含んでいない。 As a first essential component of the transparent cosmetic composition of the present invention, a chemical UV absorber is used. The chemical UV absorber can be any suitable chemical UV absorber commonly used in cosmetic compositions. Specific examples of suitable chemical UV absorbers include, but are not limited to, benzophenone-3, homosalate, ethylhexylmethoxycinnamate, avobenzone, ethylhexylsalicylate and octocrylene, and combinations thereof. The chemical UV radiation absorber is preferably present in the transparent cosmetic composition of the present invention in an amount ranging from about 1 to about 20%, more preferably from about 2 to about 15% of the total weight of the composition. . In particular, the transparent cosmetic composition of the present invention does not contain physical UV absorbers (eg, titanium oxide and zinc oxide) which are known to impair the transparency of the composition.
本発明の透明な化粧品組成物の第2の必須成分として、少なくとも1つの溶媒系が使用される。溶媒系は化学的UV線吸収剤を可溶化し、運ぶための1つ以上の適当な溶媒からなり得る。適当な溶媒の具体例にはジメチコン(例えば、日本の東京に所在の信越化学工業(株)から入手可能なDM−fluid A−6CS)、ジカプリリルカーボネート(例えば、オハイオ州シンシナティに所在のCognis Corporationから入手可能なcetiol(登録商標)CC)、ラウリルラクテート(例えば、ニュージャージー州ウェインに所在のInternational Specialty Productsから入手可能なceraphyl(登録商標)31)、ネオペンチルグリコールジヘプタノエート(例えば、ペンシルベニア州フィラデルフィアに所在のInolex Chemical Co.から入手可能なLexfeel(登録商標)7)、グリセリン及びその組合せが含まれるが、これらに限定されない。本発明の組成物が上記した化学的UV線吸収剤と特に相溶性であるシリコーンを主成分とする溶媒(例えば、ジメチコン)を含むことが好ましいが、必須ではない。溶媒は組成物の全重量の約1〜約30%、好ましくは約10〜約29%、最も好ましくは約15〜約28%の範囲の量で存在し得る。 At least one solvent system is used as the second essential component of the transparent cosmetic composition of the present invention. The solvent system may consist of one or more suitable solvents for solubilizing and carrying the chemical UV absorber. Specific examples of suitable solvents include dimethicone (eg DM-fluid A-6CS available from Shin-Etsu Chemical Co., Ltd., Tokyo, Japan), dicaprylyl carbonate (eg, Cognis, Cincinnati, Ohio). Cetiol® CC available from Corporation), lauryl lactate (eg, ceryl® 31 available from International Specialty Products, located in Wayne, NJ), neopentyl glycol diheptanoate (eg, Pennsylvania) Including, but not limited to, Lexfeel® 7), glycerin and combinations thereof available from Inolex Chemical Co., Philadelphia, USA No. The composition of the present invention preferably contains, but is not essential, a silicone-based solvent (eg, dimethicone) that is particularly compatible with the chemical UV absorbers described above. The solvent may be present in an amount ranging from about 1 to about 30%, preferably from about 10 to about 29%, most preferably from about 15 to about 28% of the total weight of the composition.
化学的UV線吸収剤が多くの場合に透明度の低い粉末形態であることは知られている。従来のサンスクリーン組成物中には化学的UV線吸収剤の溶解性を高めるために多量のエチルアルコールが使用されている。しかしながら、エチルアルコール含量が高いサンスクリーン組成物は通常、該組成物を皮膚に適用したときに刺激を引き起こす。本発明では、驚くことに、第3の必須成分、すなわちジフェニルシリコーンエラストマーゲル化剤、より具体的にはジフェニルシロキシフェニルトリメチコンを含むジフェニルシリコーンエラストマーゲル化剤を使用すると、エチルアルコールの非存在下でも化学的UV線吸収剤の溶解性が効果的に高められ得ることが知見された。理論に縛られるつもりはないが、シリコーンエラストマーゲル化剤のジフェニル基とUV吸収剤のジフェニル基が相互作用することによって組成物中のUV吸収剤の溶解性が高まると考えられる。本発明のサンスクリーン組成物中のジフェニルシロキシフェニルトリメチコンの全量は組成物の全重量の約1〜約50%の範囲であり得る。 It is known that chemical UV absorbers are often in the form of powders with low transparency. Large amounts of ethyl alcohol are used in conventional sunscreen compositions to increase the solubility of chemical UV absorbers. However, sunscreen compositions with a high ethyl alcohol content usually cause irritation when the composition is applied to the skin. In the present invention, surprisingly, the use of a third essential component, namely a diphenyl silicone elastomer gelling agent, more specifically a diphenyl silicone elastomer gelling agent comprising diphenylsiloxyphenyl trimethicone, in the absence of ethyl alcohol. However, it has been found that the solubility of chemical UV radiation absorbers can be effectively increased. While not intending to be bound by theory, it is believed that the interaction of the diphenyl group of the silicone elastomer gelling agent and the diphenyl group of the UV absorber increases the solubility of the UV absorber in the composition. The total amount of diphenylsiloxyphenyl trimethicone in the sunscreen composition of the present invention can range from about 1 to about 50% of the total weight of the composition.
本発明の1つの具体的実施形態では、ジフェニルシリコーンエラストマーゲル化剤は、ジフェニルシロキシフェニルトリメチコン及びジメチコン/フェニルビニルジメチコンクロスポリマーの混合物からなる。好ましくは、前記混合物は、混合物の全重量の約80〜約90%のジフェニルシロキシフェニルトリメチコン及び約10〜約20%のジメチコン/フェニルビニルジメチコンクロスポリマーからなる。例えば、日本の東京に所在の信越化学工業(株)から入手可能な、約85重量%のジフェニルシロキシフェニルトリメチコン及び約15重量%のジメチコン/フェニルビニルジメチコンクロスポリマーからなる混合物であるKSG−18Aが本発明の組成物中でジフェニルシリコーンエラストマーゲル化剤として使用される。KSG−18Aを本発明の組成物中でゲル化剤として使用するとき、各組成物の全重量の35〜約55%、より好ましくは約40〜約50%、最も好ましくは約44〜約46%の範囲の量で存在し得る。 In one specific embodiment of the invention, the diphenyl silicone elastomer gelling agent comprises a mixture of diphenylsiloxyphenyl trimethicone and dimethicone / phenylvinyl dimethicone crosspolymer. Preferably, the mixture comprises about 80 to about 90% diphenylsiloxyphenyl trimethicone and about 10 to about 20% dimethicone / phenylvinyl dimethicone crosspolymer based on the total weight of the mixture. For example, KSG-18A, which is a mixture of about 85% by weight diphenylsiloxyphenyl trimethicone and about 15% by weight dimethicone / phenylvinyl dimethicone cross-polymer available from Shin-Etsu Chemical Co., Ltd. located in Tokyo, Japan. Are used as diphenyl silicone elastomer gelling agents in the compositions of the present invention. When KSG-18A is used as a gelling agent in the compositions of the present invention, it is 35 to about 55%, more preferably about 40 to about 50%, most preferably about 44 to about 46, of the total weight of each composition. It can be present in an amount in the range of%.
本発明の別の具体的実施形態では、ジフェニルシリコーンエラストマーゲル化剤は、ジフェニルシロキシフェニルトリメチコン、ジメチコン/フェニルビニルジメチコンクロスポリマー、及びメチルトリメチコンの混合物からなる。好ましくは、前記混合物は、混合物の全重量の約10〜約15%のジフェニルシロキシフェニルトリメチコン、約25〜約35%のジメチコン/フェニルビニルジメチコンクロスポリマー、及び約55〜約60%のメチルトリメチコンからなる。例えば、日本の東京に所在の信越化学工業(株)から入手可能な、約13重量%のジフェニルシロキシフェニルトリメチコン、約30重量%のジメチコン/フェニルビニルジメチコンクロスポリマー、及び約57重量%のメチルトリメチコンからなる混合物であるX−21−5652Dが本発明の組成物中でジフェニルシリコーンエラストマーゲル化剤として使用される。X−21−5652Dを本発明の組成物中でゲル化剤として使用するとき、組成物の全重量の約5〜約25%、より好ましくは約7〜約20%、最も好ましくは約10〜約17%の範囲の量で存在し得る。 In another specific embodiment of the present invention, the diphenyl silicone elastomer gelling agent comprises a mixture of diphenylsiloxyphenyl trimethicone, dimethicone / phenylvinyl dimethicone crosspolymer, and methyl trimethicone. Preferably, the mixture comprises about 10 to about 15% diphenylsiloxyphenyl trimethicone, about 25 to about 35% dimethicone / phenylvinyl dimethicone crosspolymer, and about 55 to about 60% methyltrimethyl. Made of methicone. For example, about 13 wt.% Diphenylsiloxyphenyl trimethicone, about 30 wt.% Dimethicone / phenylvinyl dimethicone crosspolymer, and about 57 wt.% Methyl available from Shin-Etsu Chemical Co., Ltd., Tokyo, Japan. X-21-5562D, a mixture of trimethicone, is used as the diphenyl silicone elastomer gelling agent in the composition of the present invention. When X-21-5562D is used as a gelling agent in the composition of the present invention, it is about 5 to about 25%, more preferably about 7 to about 20%, most preferably about 10 to 10% of the total weight of the composition. It can be present in an amount in the range of about 17%.
本発明の更に別の実施形態では、ジフェニルシリコーンエラストマーゲル化剤は、上記のようなジフェニルシロキシフェニルトリメチコン及びジメチコン/フェニルビニルジメチコンクロスポリマーの第1混合物(例:KSG−18A)とジフェニルシロキシフェニルトリメチコン、ジメチコン/フェニルビニルジメチコンクロスポリマー、及びメチルトリメチコンの第2混合物(例:X−21−5652D)からなり得る。 In yet another embodiment of the invention, the diphenyl silicone elastomer gelling agent is a first mixture of diphenylsiloxyphenyl trimethicone and dimethicone / phenylvinyl dimethicone crosspolymer (eg, KSG-18A) and diphenylsiloxyphenyl as described above. It can consist of a second mixture of trimethicone, dimethicone / phenylvinyldimethicone crosspolymer, and methyltrimethicone (eg X-21-5562D).
本発明の透明な化粧品組成物の質感を更に改善するために、シリコーンゴムコアがシリコーン樹脂シェルで被覆されている複合シリコーンパウダーを場合により該組成物に添加してもよい。本発明において使用するのに適した複合シリコーンパウダーの具体例には日本の東京に所在の信越化学工業(株)から入手可能な、ビニルジメチコン/メチコンシルセスキオキサンクロスポリマーからなるKSP−100パウダーが含まれるが、これに限定されない。KSP−100複合シリコーンパウダーにより、良好な分散性/伸展性を有し、凝集の少ない独自のソフトなシルク様感触を与える。KSP−100を本発明の組成物に使用するとき、組成物の全重量の約0.5〜約10%、より好ましくは約1%〜約5%の範囲の量で存在し得る。 In order to further improve the texture of the transparent cosmetic composition of the present invention, a composite silicone powder in which a silicone rubber core is coated with a silicone resin shell may optionally be added to the composition. Specific examples of composite silicone powders suitable for use in the present invention include KSP-100 powder comprising vinyl dimethicone / methicone silsesquioxane cross-polymer available from Shin-Etsu Chemical Co., Ltd., located in Tokyo, Japan. Is included, but is not limited to this. KSP-100 composite silicone powder has good dispersibility / extensibility and gives a unique soft silk-like feel with little aggregation. When KSP-100 is used in the composition of the present invention, it may be present in an amount ranging from about 0.5 to about 10%, more preferably from about 1% to about 5% of the total weight of the composition.
更に、本発明の透明な化粧品組成物は場合により、透明性及び消費者に対する美的魅力に悪影響を及ぼすことなく組成物の粘度を向上させるための増粘剤を含み得る。好ましくは、増粘剤はジメチコン/フェニルビニルジメチコンクロスポリマーを含む。より好ましくは、増粘剤は、ジメチコン/フェニルビニルジメチコンクロスポリマーとフェニルトリメチコンの混合物、例えば日本の東京に所在の信越化学工業(株)から入手可能なKSG−18シリコーンペーストを含む。KSG−18を本発明の組成物中でゲル化剤として使用するとき、各組成物の全重量の35〜約55%、より好ましくは約40〜約50%、最も好ましくは約44〜約46%の範囲の量で存在し得る。 Furthermore, the transparent cosmetic composition of the present invention can optionally include a thickening agent to increase the viscosity of the composition without adversely affecting transparency and aesthetic appeal to the consumer. Preferably, the thickening agent comprises a dimethicone / phenylvinyl dimethicone crosspolymer. More preferably, the thickener comprises a mixture of dimethicone / phenylvinyl dimethicone crosspolymer and phenyl trimethicone, such as KSG-18 silicone paste available from Shin-Etsu Chemical Co., Ltd. located in Tokyo, Japan. When KSG-18 is used as a gelling agent in the compositions of the present invention, it is 35 to about 55%, more preferably about 40 to about 50%, most preferably about 44 to about 46, of the total weight of each composition. It can be present in an amount in the range of%.
上記した本発明の透明な化粧品組成物が無水(すなわち、水を組成物の全重量の約0.5%未満しか含有していない)であり、アルコール非含有(すなわち、エチルアルコールを組成物の全重量の約0.5%未満しか含有していない)であることが好ましい。より好ましくは、本発明の組成物はジェルエマルションの形態であり、16,000〜28,000cpsの範囲の粘度を有している。 The transparent cosmetic composition of the present invention described above is anhydrous (ie contains less than about 0.5% of the total weight of the composition) and contains no alcohol (ie ethyl alcohol in the composition). Preferably less than about 0.5% of the total weight). More preferably, the composition of the present invention is in the form of a gel emulsion and has a viscosity in the range of 16,000-28,000 cps.
透明性及び粘性を損なわない限り、所望により本発明の組成物中に他の生物活性剤を添加してもよい。ルーチンの実験で、安定な組成物を保持するのに必要な量を決定することができる。添加される生物活性剤のタイプは局所化粧品または医薬組成物中で有利に使用されているものであり得る。例えば、組成物は更に湿潤剤;しみ、角化症及びしわを処置するために使用される薬剤;並びに鎮痛剤、麻酔剤、抗アクネ剤、抗菌剤、抗酵母剤、抗真菌剤、抗ウイルス剤、ふけ防止剤、抗皮膚炎剤、抗掻痒剤、制吐剤、乗物酔い止め、抗刺激剤、抗炎症剤、抗高角質溶解剤、抗ドライスキン剤、抗乾せん剤、抗脂漏剤、アンチエージング剤、しわ防止剤、追加のサンスクリーン剤、抗ヒスタミン剤、皮膚美白剤、脱色剤、創傷治療剤、ビタミン、コルチコステロイド、セルフタンニング剤またはホルモンを含み得る。上記した生物活性剤は本発明のサンスクリーン組成物の任意成分にすぎず、組成物のサンスクリーン機能に実質的に影響を及ぼさないならば組成物から省いてもよい。 Other bioactive agents may be added to the compositions of the present invention if desired so long as the transparency and viscosity are not impaired. Routine experimentation can determine the amount necessary to maintain a stable composition. The type of bioactive agent added can be those advantageously used in topical cosmetic or pharmaceutical compositions. For example, the composition may further comprise a wetting agent; an agent used to treat stains, keratosis and wrinkles; Agents, anti-dandruff agents, anti-dermatitis agents, anti-pruritic agents, antiemetics, anti-motion sickness, anti-irritants, anti-inflammatory agents, anti-hyperkeratolytic agents, anti-dry skin agents, anti-psoriasis agents, anti-seborrheic agents It may contain anti-aging agents, anti-wrinkle agents, additional sunscreen agents, antihistamines, skin lightening agents, depigmenting agents, wound treatment agents, vitamins, corticosteroids, self-tanning agents or hormones. The bioactive agents described above are merely optional components of the sunscreen composition of the present invention and may be omitted from the composition if they do not substantially affect the sunscreen function of the composition.
本発明のサンスクリーン組成物は更に、透明性及び粘性を損なわない限り、化粧品上許容される賦形剤を含み得る。本発明のサンスクリーン組成物に配合され得る物質には湿潤剤、収れん剤、キレート化剤、界面活性剤、皮膚軟化剤、保存剤、安定化剤、保湿剤、香料等が含まれるが、これらに限定されない。これらの賦形剤が皮膚上への保護層の形成を助けることが好ましいが、必須ではない。1つ以上の賦形剤は、本発明の局所組成物中に、局所組成物の全重量の約1〜約99.9%、好ましくは約50〜約99.5%、より好ましくは約70〜約99%、最も好ましくは約80〜90%の範囲の量で存在し得る。 The sunscreen composition of the present invention may further comprise cosmetically acceptable excipients as long as the transparency and viscosity are not impaired. Substances that can be incorporated into the sunscreen composition of the present invention include wetting agents, astringents, chelating agents, surfactants, emollients, preservatives, stabilizers, humectants, fragrances, etc. It is not limited to. While it is preferred that these excipients help form a protective layer on the skin, it is not essential. One or more excipients are present in the topical composition of the present invention from about 1 to about 99.9%, preferably from about 50 to about 99.5%, more preferably about 70% of the total weight of the topical composition. May be present in an amount ranging from about 99%, most preferably about 80-90%.
例えば、本発明のサンスクリーン組成物中で使用され得る皮膚軟化剤にはステアリルアルコール、セチルアルコール、オレイルアルコール、イソセチルアルコール、脂肪アルコール、プロパン−1,2−ジオール、ブタン−1,3−ジオール、オクタデカン−2−オール、モノステアリン酸グリセリル、イソステアリン酸イソプロピル、ステアリン酸、イソステアリン酸、ステアリン酸イソセチル、ステアリン酸イソプロピル、ステアリン酸ブチル、ラウリン酸イソプロピル、ラウリン酸ヘキシル、オレイン酸デシル、パルミチン酸イソブチル、パルミチン酸セチル、パルミチン酸イソプロピル、パルミチン酸、ジメチルポリシロキサン、モノリシノール酸グリセリル、セバシン酸ジ−n−ブチル、ミリスチン酸イソプロピル、ミリスチン酸ブチル、ミリスチン酸ミリスチル、リノール酸イソプロピル、乳酸ラウリル、乳酸ミリスチル、ポリエチレングリコール、トリエチレングリコール、ラノリン、アセチル化ラノリン、ゴマ油、ヤシ油、ラッカセイ油、ヒマシ油、ミンク油、鉱油及び石油が含まれるが、これらに限定されない。 For example, emollients that can be used in the sunscreen composition of the present invention include stearyl alcohol, cetyl alcohol, oleyl alcohol, isocetyl alcohol, fatty alcohol, propane-1,2-diol, butane-1,3-diol. , Octadecan-2-ol, glyceryl monostearate, isopropyl isostearate, stearic acid, isostearic acid, isocetyl stearate, isopropyl stearate, butyl stearate, isopropyl laurate, hexyl laurate, decyl oleate, isobutyl palmitate, Cetyl palmitate, isopropyl palmitate, palmitic acid, dimethylpolysiloxane, glyceryl monoricinoleate, di-n-butyl sebacate, isopropyl myristate, myristic acid Includes chill, myristyl myristate, isopropyl linoleate, lauryl lactate, myristyl lactate, polyethylene glycol, triethylene glycol, lanolin, acetylated lanolin, sesame oil, coconut oil, peanut oil, castor oil, mink oil, mineral oil and petroleum However, it is not limited to these.
長い貯蔵期間を与えるために本発明のサンスクリーン組成物に各種保存剤を添加することもできる。適当な保存剤にはソルビン酸カリウム、イミダゾリジニル尿素、p−ヒドロキシベンゾエート、p−ヒドロキシ安息香酸エステル、CTFA指定のパラベン、エチルヘキシルグリセリン、カプリリルグリコール/フェノキシエタノール/ヘキシレングリコール等が含まれるが、これらに限定されない。本発明のサンスクリーン組成物中に使用するのに適した他の保存剤は、International Cosmetic Ingredient Dictionary and Handbook,第12版(2004)に開示されており、その全文を参照により本明細書に組み入れる。 Various preservatives can also be added to the sunscreen composition of the present invention to provide a long shelf life. Suitable preservatives include potassium sorbate, imidazolidinyl urea, p-hydroxybenzoate, p-hydroxybenzoate, CTFA-designated paraben, ethylhexyl glycerin, caprylyl glycol / phenoxyethanol / hexylene glycol, and the like. It is not limited. Other preservatives suitable for use in the sunscreen compositions of the present invention are disclosed in International Cosmetic Ingredient Dictionary and Handbook, 12th Edition (2004), which is incorporated herein by reference in its entirety. .
使用され得る保湿剤にはグリセロール、ポリアルキレングリコール及びアルキレンポリオール、並びにその混合物を含む多価アルコール、ヒアルロン酸、尿素、グリセリン、ソルビトール、2−ピロリドン−5−カルボン酸ナトリウム、可溶性コラーゲン、ジブチルフタレート及びゼラチンが含まれるが、これらに限定されない。 Humectants that can be used include polyhydric alcohols including glycerol, polyalkylene glycols and alkylene polyols, and mixtures thereof, hyaluronic acid, urea, glycerin, sorbitol, sodium 2-pyrrolidone-5-carboxylate, soluble collagen, dibutyl phthalate and Gelatin is included, but is not limited to these.
本発明の透明なサンスクリーン組成物は、場合により組成物を消費者に対してより魅力的とするのに十分な量の香料を含み得る。好ましい香料の量は組成物の全重量の約0.01〜約10%である。 The clear sunscreen composition of the present invention may optionally contain a sufficient amount of perfume to make the composition more attractive to the consumer. A preferred perfume amount is from about 0.01 to about 10% of the total weight of the composition.
上記したサンスクリーン組成物は、ヒト皮膚をUV線の有害な作用から保護するための皮膚保護または皮膚治療製品として特に有用である。前記サンスクリーン組成物を目、頬、顎、首及び他の顔面域に適用してもよく、潜在的にUV線に敏感な他の身体域に適用してもよい。 The sunscreen composition described above is particularly useful as a skin protection or skin treatment product for protecting human skin from the harmful effects of UV radiation. The sunscreen composition may be applied to the eyes, cheeks, chin, neck, and other facial areas, and may be applied to other body areas that are potentially sensitive to UV radiation.
本発明のサンスクリーン組成物に関する使用方法は組成物の最終的に意図する用途に依存する。例えば、本発明のサンスクリーン組成物は、特に強い日光の暴露からときどき保護するために必要に応じて皮膚に対して適用され得る。或いは、サンスクリーン組成物を皮膚に対して定期的に適用してもよく、こうするほうが好ましい。例えば、サンスクリーン組成物を約1回/週〜約3回/日の範囲の頻度で定期的に適用し得る。 The method of use for the sunscreen composition of the present invention depends on the ultimate intended use of the composition. For example, the sunscreen composition of the present invention can be applied to the skin as needed to provide occasional protection from particularly intense sun exposure. Alternatively, the sunscreen composition may be applied periodically to the skin, and this is preferred. For example, the sunscreen composition may be applied periodically at a frequency in the range of about 1 time / week to about 3 times / day.
下記実施例は本発明の新規な組成物及び方法を更に説明するが、本発明はこれらに限定されない。 The following examples further illustrate the novel compositions and methods of the present invention, but the invention is not limited thereto.
以下の組成物は、エマルションジェルの形態の本発明の幾つかの好ましい実施形態の例を与える。 The following compositions give examples of some preferred embodiments of the invention in the form of emulsion gels.
組成物AComposition A
組成物BComposition B
組成物CComposition C
以下の実施例は、様々なゲル化物質(太字で示す)を用いた組成物の比較結果を示す。成分すべてを一緒に混合し、透明性及び安定性について24時間観察した。
表1から明らかなように、十分な安定性で透明性を維持した組成物は本発明のジフェニルシリコーンエラストマーゲル化剤(すなわち、X−21−5652Dゲル化剤)を含む組成物だけであった。 As can be seen from Table 1, the composition containing the diphenyl silicone elastomer gelling agent of the present invention (ie, X-21-5562D gelling agent) was the only composition that maintained sufficient stability and transparency. .
以下の実施例は、上記した実施例2の基本組成物1中に各種の異なる溶媒を含有する組成物の比較結果を示す。各溶媒を実施例2の基本組成物1中に混合し、透明性及び安定性について24時間観察した。
表2から明らかなように、特定の溶媒しか安定で透明なジェルを与えず、他の溶媒では組成物の安定性を損ねたり、またはジェル組成物を生成しない。 As can be seen from Table 2, only certain solvents give stable and transparent gels, while other solvents do not compromise the stability of the composition or produce gel compositions.
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77811606P | 2006-03-01 | 2006-03-01 | |
US60/778,116 | 2006-03-01 | ||
PCT/US2007/062846 WO2007103654A1 (en) | 2006-03-01 | 2007-02-27 | Clear sunscreen gels and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009528377A JP2009528377A (en) | 2009-08-06 |
JP4964253B2 true JP4964253B2 (en) | 2012-06-27 |
Family
ID=38475197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008557463A Active JP4964253B2 (en) | 2006-03-01 | 2007-02-27 | Transparent sunscreen gel and method of use |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1996155A1 (en) |
JP (1) | JP4964253B2 (en) |
KR (1) | KR101068276B1 (en) |
AU (1) | AU2007223713B2 (en) |
CA (1) | CA2642783A1 (en) |
WO (1) | WO2007103654A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100303743A1 (en) * | 2007-09-26 | 2010-12-02 | John Joseph Kennan | Personal Care Compositions Containing Hydrophobic Silicone-Organic Gel Blends |
WO2010129313A2 (en) | 2009-05-04 | 2010-11-11 | Elc Management Llc | Cosmetic compositions comprising cyanodiphenylacrylates |
US8765156B2 (en) | 2009-05-04 | 2014-07-01 | Elc Management Llc | Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound |
WO2012149355A1 (en) * | 2011-04-27 | 2012-11-01 | Isp Investments Inc. | Clear wet sprays and gels |
DE202013103395U1 (en) * | 2013-07-26 | 2013-08-13 | Sasol Germany Gmbh | Transparent sunscreen compositions and their use |
US10066123B2 (en) | 2013-12-09 | 2018-09-04 | 3M Innovative Properties Company | Curable silsesquioxane polymers, compositions, articles, and methods |
US10172783B2 (en) | 2014-06-04 | 2019-01-08 | L'oreal | High UV protection alcohol-free anhydrous clear system |
WO2015195391A1 (en) | 2014-06-20 | 2015-12-23 | 3M Innovative Properties Company | Adhesive compositions comprising a silsesquioxane polymer crosslinker, articles and methods |
WO2015195355A1 (en) | 2014-06-20 | 2015-12-23 | 3M Innovative Properties Company | Adhesive compositions comprising a silsesquioxane polymer crosslinker, articles and methods |
JP2017519081A (en) | 2014-06-20 | 2017-07-13 | スリーエム イノベイティブ プロパティズ カンパニー | Curable polymer and method comprising a silsesquioxane polymer core and a silsesquioxane polymer outer layer |
WO2016048736A1 (en) | 2014-09-22 | 2016-03-31 | 3M Innovative Properties Company | Curable polymers comprising silsesquioxane polymer core silsesquioxane polymer outer layer, and reactive groups |
US9957416B2 (en) | 2014-09-22 | 2018-05-01 | 3M Innovative Properties Company | Curable end-capped silsesquioxane polymer comprising reactive groups |
WO2016119028A1 (en) * | 2015-01-29 | 2016-08-04 | L'oreal | Transparent sunscreen composition |
JP7351837B2 (en) * | 2018-08-10 | 2023-09-27 | 株式会社 資生堂 | oil-based cosmetics |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05124945A (en) * | 1991-11-01 | 1993-05-21 | Kao Corp | Ultraviolet ray protecting composition |
FR2715294B1 (en) * | 1994-01-26 | 1996-03-22 | Oreal | Anhydrous cosmetic or dermatological composition containing the combination of a silicone oil and a wax of an ethylene homo- or copolymer. |
DE19707309B4 (en) * | 1997-02-11 | 2004-08-12 | Lancaster Group Gmbh | Solid cosmetic compositions based on solidified oils |
DE19824418A1 (en) | 1998-05-30 | 1999-12-02 | Goldschmidt Ag Th | Transparent sunscreen gels with high solar protection factors |
US6290938B1 (en) * | 1998-07-30 | 2001-09-18 | The Procter & Gamble Company | Sunscreen compositions |
US6936241B2 (en) | 2001-08-17 | 2005-08-30 | The Procter & Gamble Company | Sunscreen composition |
US6916464B2 (en) * | 2002-12-20 | 2005-07-12 | L'oreal | Sunscreen compositions |
WO2004082644A1 (en) * | 2003-03-19 | 2004-09-30 | Kanebo Cosmetics Inc. | Cosmetic preparation |
JP4250093B2 (en) * | 2004-01-16 | 2009-04-08 | 日本メナード化粧品株式会社 | Cosmetics |
GB0406037D0 (en) * | 2004-03-18 | 2004-04-21 | Ici Plc | Metal oxide dispersion |
JP2005272389A (en) * | 2004-03-25 | 2005-10-06 | Kose Corp | Oil-in-water type emulsifying cosmetic |
-
2007
- 2007-02-27 JP JP2008557463A patent/JP4964253B2/en active Active
- 2007-02-27 AU AU2007223713A patent/AU2007223713B2/en active Active
- 2007-02-27 KR KR1020087021280A patent/KR101068276B1/en active IP Right Grant
- 2007-02-27 CA CA002642783A patent/CA2642783A1/en not_active Abandoned
- 2007-02-27 EP EP07757517A patent/EP1996155A1/en not_active Withdrawn
- 2007-02-27 WO PCT/US2007/062846 patent/WO2007103654A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
KR101068276B1 (en) | 2011-09-28 |
CA2642783A1 (en) | 2007-09-13 |
JP2009528377A (en) | 2009-08-06 |
AU2007223713B2 (en) | 2009-11-19 |
KR20080090557A (en) | 2008-10-08 |
AU2007223713A1 (en) | 2007-09-13 |
WO2007103654A1 (en) | 2007-09-13 |
EP1996155A1 (en) | 2008-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4964253B2 (en) | Transparent sunscreen gel and method of use | |
US20080206172A1 (en) | Clear sunscreen gels and methods of use thereof | |
JP6766018B2 (en) | Sunscreen composition | |
US20070207113A1 (en) | Personal care and cosmetic compositions comprising renewably-based, biodegradable 1,3-propanediol | |
JP2017122075A (en) | Oil-in-water skin cosmetic | |
ES2292944T3 (en) | SPHERICAL POWDER COMPONENTS AND SOLID COSMETIC COMPOSITIONS THAT INCLUDE THE SAME. | |
EA028536B1 (en) | Cosmetic composition | |
JP6070571B2 (en) | Deodorant composition | |
CN112656729A (en) | Oil control isolation composition and preparation method and application thereof | |
JP6600455B2 (en) | Oil-in-water emulsified cosmetic | |
EP1139999A1 (en) | Topical compositions including deodorant compositions | |
JP2015187183A (en) | Makeup-remover gel containing jojoba oil | |
JP6445981B2 (en) | Sunscreen composition comprising fatty acid and nonionic linear polymer | |
JP2019189663A (en) | Oil-in-water emulsion cosmetic | |
JP6865522B2 (en) | Underwater oil type UV protection cosmetics | |
JPH1149655A (en) | Skin lotion | |
CA2911686A1 (en) | Synergistic photoprotective compositions | |
US20220395436A1 (en) | Gel composition with high oil content, the preparation method and the use of the same | |
JP2017122059A (en) | Body odor suppressing agent | |
JP2009137909A (en) | Astringent cosmetic | |
JP6995182B1 (en) | Underwater oil type emulsified cosmetic | |
KR102419912B1 (en) | Mist type sunscreen cosmetic composition | |
EP4257111A1 (en) | Personal care compositions | |
WO2021127768A1 (en) | Anti-perspirant composition, cosmetic use and method for applying same | |
CA3171605A1 (en) | Topical composition based on porous particles and a crosspolymer comprising adipic acid and neopentylglycol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110421 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110531 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110818 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110825 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110922 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111018 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120112 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120119 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120228 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120321 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120327 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4964253 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150406 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |